Therapeutics News and Research

RSS

Using nanodiamonds to see smaller

Many of the most fundamental, life governing biological processes take place at size and time scales that remain invisible with current imaging technologies. Understanding how the molecules that underlie these processes move, interact and change could pave the way for new treatments, cures and the development of novel drug therapies.

7 Apr 2017

Tumor necrosis factor may help control blood pressure, study suggests

Investigators at the Ted Rogers Centre for Heart Research have discovered a surprising new role for tumor necrosis factor (TNF): namely, that it is a major regulator of small blood vessel function, the key determinant of blood pressure. The study is published online today in Nature Communications.

6 Apr 2017

Metabolic syndrome is the new 'silent killer', warn researchers

For decades, American waistlines have been expanding and there is increasing cause for alarm. Researchers from the Charles E. Schmidt College of Medicine at Florida Atlantic University make the case that metabolic syndrome -- a cluster of three of more risk factors that include abdominal obesity, high triglycerides, high blood pressure, abnormal lipids, and insulin resistance, a precursor of type 2 diabetes -- is the new "silent killer," analogous to hypertension in the 1970s.

6 Apr 2017

Antibody treatment protects non-human primates against deadly Marburg and Ravn viruses

An antibody treatment successfully protected nonhuman primates against the deadly Marburg and Ravn viruses even when given five days after becoming infected, according to the latest findings of a collaborative team from The University of Texas Medical Branch at Galveston, Mapp Biopharmaceutical Inc., and Vanderbilt University. The findings are now available in Science Translational Medicine.

6 Apr 2017

Study shows how chemical modification in the retinal can improve vision

A light-sensing pigment found in everything from bacteria to vertebrates can be biochemically manipulated to reset itself, an important therapeutic advantage, according to new research out of Case Western Reserve University School of Medicine.

6 Apr 2017

MSU and Venn Therapeutics develop promising therapy to delay B16 melanoma tumor growth

Michigan State University researchers presented promising cancer therapy results at the American Association for Cancer Research International Meeting in Washington, DC.

5 Apr 2017

Researchers achieve new step towards treatment of myotubular myopathy using gene therapy

A team of researchers in France, led by Dr. Ana Buj-Bello (Genethon/Inserm) and teams at the University of Washington and Harvard Medical School in the United States, achieved a new step towards the treatment of myotubular myopathy by gene therapy.

5 Apr 2017

Hebrew University announces launch of new Center for conducting research on cannabinoids

The Hebrew University of Jerusalem has announced the launch of a Multidisciplinary Center on Cannabinoid Research.

5 Apr 2017

Yoga may be valuable adjunct to conventional therapies for ulcerative colitis

Patients with ulcerative colitis, a chronic inflammatory bowel disease, often relapse at times of stress.

5 Apr 2017

Tumor microenvironment poses unique challenges for effective ovarian cancer T-cell therapy

Fred Hutchinson Cancer Research Center immunotherapy researchers Drs. Kristin Anderson and Philip Greenberg and their colleagues are working on ways to tweak their team's early successes with T-cell therapy for leukemia to apply to solid tumors.

5 Apr 2017

Liver shows positive response to leptin therapy in patients with partial lipodystrophy, study finds

Researchers at Michigan Medicine have found the livers of patients with a rare disease that affects metabolism have responded positively to leptin therapy.

5 Apr 2017

MPA approves Renishaw study into chronic drug delivery system in Parkinson's patients

The Medicines Agency of Sweden, MPA, has authorised Herantis Pharma Plc and Renishaw plc’s randomised, placebo-controlled Phase 1-2 clinical study, for the investigation of Cerebral Dopamine Neurotrophic Factor (CDNF) and Renishaw’s chronic drug delivery system, in Parkinson’s patients.

4 Apr 2017

Pharmaceuticalization of today’s sleep

The pharmaceuticalisation of sleep, put simply, refers to the ways in which sleep becomes a site for manipulation or augmentation through pharmaceutical use. There are different ways in which sleep can be pharmaceuticalised – for example we can use pharmaceuticals to induce sleep, to consolidate broken sleep, or to prevent or delay sleep.

4 Apr 2017

Scientists develop novel technique to screen non-coding DNA of genome for diseases

Researchers have developed a method to swiftly screen the non-coding DNA of the human genome for links to diseases that are driven by changes in gene regulation.

4 Apr 2017

New drug compound could cut number of hot flushes in menopausal women

Women plagued by frequent hot flushes during the menopause could cut the number of flushes by almost three-quarters, thanks to a new drug compound.

3 Apr 2017

Extreme short and long telomeres linked to increased cancer risk

The length of the telomere "caps" of DNA that protect the tips of chromosomes may predict cancer risk and be a potential target for future therapeutics, University of Pittsburgh Cancer Institute scientists will report today at the AACR Annual Meeting in Washington, D.C.

3 Apr 2017

Researchers develop new technologies to measure key proteins that serve as markers for tumors

Dr. Amanda Paulovich, whose lab has a leading role in the Beau Biden Cancer Moonshot, will speak April 5 at the American Association for Cancer Research annual meeting about her lab's pioneering methods to measure proteins that serve as tumor markers.

3 Apr 2017

Therapeutics News and Research

Using nanodiamonds to see smaller

Tumor necrosis factor may help control blood pressure, study suggests

Metabolic syndrome is the new 'silent killer', warn researchers

Antibody treatment protects non-human primates against deadly Marburg and Ravn viruses

Study shows how chemical modification in the retinal can improve vision

MSU and Venn Therapeutics develop promising therapy to delay B16 melanoma tumor growth

Researchers achieve new step towards treatment of myotubular myopathy using gene therapy

Hebrew University announces launch of new Center for conducting research on cannabinoids

Yoga may be valuable adjunct to conventional therapies for ulcerative colitis

Tumor microenvironment poses unique challenges for effective ovarian cancer T-cell therapy

Liver shows positive response to leptin therapy in patients with partial lipodystrophy, study finds

MPA approves Renishaw study into chronic drug delivery system in Parkinson's patients

Pharmaceuticalization of today’s sleep

Scientists develop novel technique to screen non-coding DNA of genome for diseases

New drug compound could cut number of hot flushes in menopausal women

Extreme short and long telomeres linked to increased cancer risk

Researchers develop new technologies to measure key proteins that serve as markers for tumors

Horizon 2020 program selects Precision NanoSystems’ NanoAssemblr platform to develop RNA medicines

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Antibe Therapeutics grants options to purchase common shares

Next-generation therapeutics eBook eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News